According to the disclosure document released by hkex on August 29th,$TENCENT (00700.HK)$,$HSBC HOLDINGS (00005.HK)$And so on to repurchase shares.
Please use your Futubull account to access the feature.$TENCENT (00700.HK)$Repurchased 2.66 million shares of common stock on August 28th, involving an amount of 1.001 billion Hong Kong dollars, with a repurchase price per share ranging from 383 Hong Kong dollars to 372.4 Hong Kong dollars.
Since the share buyback authorization resolution, the accumulated number of repurchased securities is 0.126 billion shares, accounting for 1.333% of the number of shares issued when the ordinary resolution was passed.
Repurchased 3.394 million ordinary shares on May 31, involving an amount of HKD234 million, with a repurchase price per share ranging from HKD69.1 to HKD68.55.$HSBC HOLDINGS (00005.HK)$Repurchased 3.7832 million common shares on August 27, involving an amount of 0.257 billion Hong Kong dollars, with a repurchase price per share ranging from 67.95 Hong Kong dollars to 67.5 Hong Kong dollars.
Repurchased 1 million ordinary shares on June 3, involving an amount of HKD60.6193 million, with a repurchase price per share ranging from HKD61.15 to HKD59.8.$AIA (01299.HK)$Repurchased 1.15 million common shares on August 28, involving an amount of 63.9184 million Hong Kong dollars, with a repurchase price per share ranging from 56.2 Hong Kong dollars to 55.1 Hong Kong dollars.
Since the share buyback authorization resolution, the accumulated number of repurchased securities is 0.27 billion shares, accounting for 2.407% of the number of shares issued when the ordinary resolution was passed.
Asymchem Laboratories (06821.HK)$KUAISHOU-W (01024.HK)$On August 28, a total of 1.2675 million weighted voting right stocks were repurchased, involving an amount of 49.9898 million Hong Kong dollars, with a repurchase price ranging from 39.95 Hong Kong dollars to 39.05 Hong Kong dollars per share.
Since the share buyback authorization resolution, the cumulative number of repurchased securities is 34.7995 million shares, accounting for 0.802% of the number of shares issued at the time of the ordinary resolution.
Repurchased 2.8 million weighted voting right shares on June 3, involving an amount of HKD50.0474 million, with a repurchase price per share ranging from HKD17.94 to HKD17.82.$CSPC PHARMA (01093.HK)$On August 28, a total of 10.5 million ordinary shares were repurchased, involving an amount of 49.6407 million Hong Kong dollars, with a repurchase price ranging from 4.83 Hong Kong dollars to 4.69 Hong Kong dollars per share.
Since the share buyback authorization resolution, the cumulative number of repurchased securities is 71.61 million shares, accounting for 0.602% of the number of shares issued at the time of the ordinary resolution.
Details of share buybacks by listed companies can be found in the figure below:
What is share buyback?
Share buyback refers to a behavior of listed companies using cash to repurchase a certain amount of outstanding shares on the stock market. After the share buyback, the company can cancel the repurchased shares. This will reduce the number of outstanding shares in circulation, thus achieving positive effects such as market cap management, stock-based incentive, and stable stock price.